AU2003260316A1 - Regulation of human hepsin - Google Patents

Regulation of human hepsin

Info

Publication number
AU2003260316A1
AU2003260316A1 AU2003260316A AU2003260316A AU2003260316A1 AU 2003260316 A1 AU2003260316 A1 AU 2003260316A1 AU 2003260316 A AU2003260316 A AU 2003260316A AU 2003260316 A AU2003260316 A AU 2003260316A AU 2003260316 A1 AU2003260316 A1 AU 2003260316A1
Authority
AU
Australia
Prior art keywords
regulation
human hepsin
hepsin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260316A
Other versions
AU2003260316A8 (en
Inventor
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003260316A1 publication Critical patent/AU2003260316A1/en
Publication of AU2003260316A8 publication Critical patent/AU2003260316A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976Trypsin; Chymotrypsin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
AU2003260316A 2002-07-23 2003-07-22 Regulation of human hepsin Abandoned AU2003260316A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39761402P 2002-07-23 2002-07-23
US60/397,614 2002-07-23
US45997603P 2003-04-04 2003-04-04
US60/459,976 2003-04-04
PCT/EP2003/007958 WO2004009803A2 (en) 2002-07-23 2003-07-22 Regulation of human hepsin

Publications (2)

Publication Number Publication Date
AU2003260316A1 true AU2003260316A1 (en) 2004-02-09
AU2003260316A8 AU2003260316A8 (en) 2004-02-09

Family

ID=30773030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260316A Abandoned AU2003260316A1 (en) 2002-07-23 2003-07-22 Regulation of human hepsin

Country Status (2)

Country Link
AU (1) AU2003260316A1 (en)
WO (1) WO2004009803A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001064A (en) 2004-07-26 2007-04-12 Genentech Inc Methods and compositions for modulating hepatocyte growth factor activation.
EP2275547B1 (en) 2004-12-13 2014-03-05 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
JP2009540835A (en) 2006-06-22 2009-11-26 ジェネンテック・インコーポレーテッド Methods and compositions for targeting hepsin
EA200801823A1 (en) * 2008-06-19 2009-04-28 Ано "Институт Молекулярной Диагностики" STRAIN-PRODUCER OF SOLUBLE FORM OF RECOMBINANT HEPSIN PERSON (HPNTM)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268165B1 (en) * 1997-03-19 2001-07-31 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
AU2002230845A1 (en) * 2000-12-20 2002-07-01 Isis Pharmaceuticals, Inc. Antisense modulation of hepsin expression
AU2002240336A1 (en) * 2001-02-14 2002-08-28 Tularik Inc. Methods for the diagnosis and treatment of tumors employing the hepsin gene
US6482630B2 (en) * 2001-03-29 2002-11-19 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

Also Published As

Publication number Publication date
WO2004009803A2 (en) 2004-01-29
AU2003260316A8 (en) 2004-02-09
WO2004009803A3 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2003236991A1 (en) Representations of processes
AU2003225088A1 (en) Regulation of tnf-alpha
AU2003230566A1 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
AU2003260316A1 (en) Regulation of human hepsin
AU2003245262A1 (en) Reduction of hair growth
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2003266271A1 (en) Regulation of human esterase
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002352253A1 (en) Regulation of human sialyltransferase
AU2003240688A1 (en) Regulation of human kinase
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2003250830A1 (en) Regulation of human subtilase-like serine protease
AU2003251665A1 (en) Regulation of human esterase
AU2003287959A1 (en) Regulation of human pde6b
AU2003218668A1 (en) Regulation of human lipase
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2003201160A1 (en) Regulation of human sulfatase
AU5033101A (en) Regulation of human heparanase-like enzyme
AU2002229681A1 (en) Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase
AU2003280985A1 (en) Regulation of human tripeptidyl peptidase ii

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase